Evidence map›Paper›PMID 36252779›Full record

ReviewEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2023

Paraganglioma of the Head and Neck: A Review.

Lyndsey Sandow, Rajat Thawani, Myung Sun Kim, Michael C Heinrich

Erratum issuedOpen access · greenAbstract readReview
In one paragraph

Review in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Vascular Supply of Laryngeal Paragangliomas: Case Report and Systematic Review.World journal of otorhinolaryngology - head and neck surgery · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Plasma cells and plasmacytoid features in thyroid lesions.Virchows Archiv : an international journal of pathology · 2026
    Review
  17. Article
  18. Article
  19. [Analysis of misdiagnosis causes of vagal paraganglioma].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lyndsey SandowDepartment of Medicine, Oregon Health and Science University, Portland, Oregon.
Rajat ThawaniDivision of Hematology and Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon. Electronic address: thawani@ohsu.edu.
Myung Sun KimDivision of Hematology and Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
Michael C HeinrichDivision of Hematology and Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
Oregon Health & Science University · US

Funding

Novel models for functional profiling of germline SDH variants associated with cancerR21CA263400 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HEINRICH, MICHAEL C · 2021 to 2022
$320k
Functional profiling of germline SDH variants associated with cancer susceptibilityI01BX005358 · VA · PORTLAND VA MEDICAL CENTER · PI HEINRICH, MICHAEL C · 2021 to 2025
–
BLRD VA I01 BX000338BLRD VA I01 BX005358NCI NIH HHS R21 CA263400
6 · The paper itself

Abstract

objectiveTo review the epidemiology, presentation, diagnosis, and management of head and neck paragangliomas.

methodsA literature review of english language papers with focus on most current literature.

resultsParagangliomas (PGLs) are a group of neuroendocrine tumors that arise in the parasympathetic or sympathetic ganglia. Head and neck PGLs (HNPGLs) comprise 65% to 70% of all PGLs and account for 0.6% of all head and neck cancers. The majority of HNPGLs are benign, and 6% to 19% of all HNPGLs develop metastasis outside the tumor site and significantly compromise survival. PGLs can have a familial etiology with germline sequence variations in different susceptibility genes, with the gene encoding succinate dehydrogenase being the most common sequence variation, or they can arise from somatic sequence variations or fusion genes. Workup includes biochemical testing to rule out secretory components, although it is rare in HNPGLs. In addition, imaging modalities, such as computed tomography and magnetic resonance imaging, help in monitoring in surgical planning. Functional imaging with DOTATATE-positron emission tomography, 18F-fluorodeoxyglucose, or 18F-fluorohydroxyphenylalanine may be necessary to rule out sites of metastases. The management of HNPGLs is complex depending on pathology, location, and aggressiveness of the tumor. Treatment ranges from observation to resection to systemic treatment. Similarly, the prognosis ranges from a normal life expectancy to a 5-year survival of 11.8% in patients with distant metastasis.

conclusionOur review is a comprehensive summary of the incidence, mortality, pathogenesis, presentation, workup and management of HNPGLs.

Indexed as

Head and Neck NeoplasmsParaganglioma, Extra-AdrenalFluorodeoxyglucose F18HumansParagangliomaSuccinate DehydrogenaseTomography, X-Ray ComputedFluorodeoxyglucose F18Succinate Dehydrogenasehead and neck neoplasmsneuroendocrine tumorsparaganglioma

Identifiers

PMID36252779
PMCPMC9979593
OpenAlexW4306318984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.